Beta hydroxybutyrate—a ketone body produced in the liver—could be key to regulating hypertension in heart patients who aren’t able to exercise, according to research out of the University of Toledo.

CMS is reconsidering its reimbursement practices for ambulatory blood pressure monitoring (ABPM) at the request of the American Heart Association and the American Medical Association, which authored a joint letter urging the agency to cover ABPM for a broader range of indications.

For the first time, the World Health Organization (WHO) has included ambient noise from leisure-time activities in its guidelines on how cumulative exposure to high volumes can lead to health problems, including stress, hypertension and heart disease.

A report published in Circulation: Cardiovascular Quality and Outcomes found a faith-based program in traditionally black churches was able to lower systolic blood pressure among attendants by an average 5.8 mm Hg—a result that more typical public education programs failed to replicate.

Three days’ worth of home blood pressure monitoring (HBPM) data is enough to confirm a diagnosis of clinical hypertension and initiate treatment, according to research published in the Journal of the American Heart Association.

Adherence to a “Southern diet” may be the biggest driver of racial disparities in hypertension rates among black and white adults in the U.S., according to a prospective cohort study published Oct. 2 in JAMA.

Women who suffer from peripartum cardiomyopathy (PPCM) will likely be clinically asymptomatic seven years after they give birth, according to research published in the Journal of the American Heart Association Oct. 3—but it’s also likely they’ll develop enduring diastolic dysfunction and reduced exercise capacity in the same window.

The consequences of sexual harassment and assault—the former of which up to 81 percent of women say they’ve experienced at some point in their lifetime—aren’t just mental, according to a study presented at the North American Menopause Society symposium in San Diego. They’re also physical, putting women at a higher risk for hypertension and sleep disorders.

Metabolic parameters like body weight, blood pressure, cholesterol and blood sugar levels are established risk factors for cardiovascular disease. But a new study suggests it’s not just abnormal measures of these components that portend risk—significant fluctuations in these areas are independently linked to all-cause mortality, heart attack and stroke among otherwise healthy people.

SAN DIEGO — An endovascular ultrasound-based renal denervation (RDN) approach led to greater reductions in blood pressure than radiofrequency ablation in patients with resistant hypertension, according to the first randomized trial to compare the techniques.

A recent meta-analysis published in Circulation: Cardiovascular Quality and Outcomes suggests the benefit of anticoagulation for pulmonary arterial hypertension (PAH) may depend on the subtype of the condition. Mortality rates improved with anticoagulation for patients with idiopathic PAH but worsened for those with scleroderma-associated PAH.

About 14 percent of older adults hospitalized for common, non-cardiac conditions were discharged with more intensive blood pressure medication, according to an analysis published in The BMJ. The concerning part: More than half of those patients actually demonstrated good blood pressure (BP) control in an outpatient setting, suggesting overtreatment from hospital physicians.